Enclave Advisors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Sell
3,314
-245
-7% -$35.7K 0.06% 92
2026
Q1
$514K Hold
3,559
0.07% 90
2025
Q4
$510K Sell
3,559
-357
-9% -$52.6K 0.07% 88
2025
Q3
$602K Sell
3,916
-13
-0.3% -$2.03K 0.09% 73
2025
Q2
$626K Sell
3,929
-120
-3% -$19.6K 0.1% 69
2025
Q1
$690K Sell
4,049
-62
-2% -$10.4K 0.12% 64
2024
Q4
$689K Sell
4,111
-1
-0% -$170 0.11% 69
2024
Q3
$712K Buy
+4,112
New +$698K 0.12% 69

Other funds holding PG

Enclave Advisors's PG Position: Q2 2026 in Review

Enclave Advisors reduced its Procter & Gamble (PG) stake by 6.9% in Q2 2026, selling an estimated $35.7K and leaving 3,314 shares worth $486K. The position accounts for 0.06% of the portfolio, ranked #92.

Enclave Advisors first reported a position in PG in Q3 2024 and has held it in 8 quarters since. The position peaked at $712K in Q3 2024. 1,018 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Enclave Advisors held 3,314 shares of Procter & Gamble worth $486K as of Q2 2026.
  • Enclave Advisors sold 245 Procter & Gamble shares in Q2 2026, an estimated $35.7K.
  • Procter & Gamble made up 0.06% of Enclave Advisors's portfolio in Q2 2026, its #92 holding.
  • Enclave Advisors first reported a position in Procter & Gamble in Q3 2024 and has held it in 8 quarters since.
  • Enclave Advisors's Procter & Gamble position peaked at $712K in Q3 2024.
  • 1,018 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Enclave Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.